E-LIB Suche - Ergebnisse für: Lippe, Ralph

1

Efficacy and Safety of Risankizumab for Active Psoriatic Ar..:

Östör, Andrew ; Van den Bosch, Filip ; Papp, Kim...
Rheumatology and Therapy. 11 (2024) 3 - p. 633-648 , 2024

Link: https://doi.org/10.1007/..

2

Efficacy and Safety of Risankizumab for Active Psoriatic Ar..:

Kristensen, Lars Erik ; Keiserman, Mauro ; Papp, Kim...
Rheumatology and Therapy. 11 (2024) 3 - p. 617-632 , 2024

Link: https://doi.org/10.1007/..

3

Safety Profile of Upadacitinib up to 5 Years in Psoriatic A..:

Burmester, Gerd R. ; Stigler, Jayne ; Rubbert-Roth, Andrea...
Rheumatology and Therapy. 11 (2024) 3 - p. 737-753 , 2024

Link: https://doi.org/10.1007/..

4

Association Between Achievement of Clinical Disease Control..:

Kavanaugh, Arthur ; Mease, Philip ; Gossec, Laure...
ACR Open Rheumatology. , 2024

Link: https://doi.org/10.1002/..

5

Malignancy in the Upadacitinib Clinical Trials for Rheumato..:

Rubbert-Roth, Andrea ; Kakehasi, Adriana M. ; Takeuchi, Tsutomu...
Rheumatology and Therapy. 11 (2023) 1 - p. 97-112 , 2023

Link: https://doi.org/10.1007/..

6

MACE and VTE across upadacitinib clinical trial programmes ..:

Charles-Schoeman, Christina ; Choy, Ernest ; McInnes, Iain B...
RMD Open. 9 (2023) 4 - p. e003392 , 2023

Link: https://doi.org/10.1136/..

7

Differential properties of Janus kinase inhibitors in the t..:

Taylor, Peter C ; Choy, Ernest ; Baraliakos, Xenofon...
Rheumatology. 63 (2023) 2 - p. 298-308 , 2023

Link: https://doi.org/10.1093/..

8

Efficacy and Safety of Upadacitinib in Patients with Psoria..:

McInnes, Iain B. ; Kato, Koji ; Magrey, Marina...
Rheumatology and Therapy. , 2022

Link: https://doi.org/10.1007/..

9

Effect of upadacitinib on reducing pain in patients with ac..:

McInnes, Iain B ; Ostor, Andrew J K ; Mease, Philip J...
RMD Open. 8 (2022) 1 - p. e002049 , 2022

Link: https://doi.org/10.1136/..

10

Disease Control with Upadacitinib in Patients with Psoriati..:

Mease, Philip ; Kavanaugh, Arthur ; Gladman, Dafna...
Rheumatology and Therapy. 9 (2022) 4 - p. 1181-1191 , 2022

Link: https://doi.org/10.1007/..

11

Patient-Reported Outcomes in Psoriatic Arthritis Patients w..:

Strand, Vibeke ; Van den Bosch, Filip ; Ranza, Roberto...
Rheumatology and Therapy. 8 (2021) 4 - p. 1827-1844 , 2021

Link: https://doi.org/10.1007/..

12

Safety Profile of Upadacitinib up to 3 Years in Psoriatic A..:

Burmester, Gerd R. ; Winthrop, Kevin ; Blanco, Ricardo...
Rheumatology and Therapy. 9 (2021) 2 - p. 521-539 , 2021

Link: https://doi.org/10.1007/..

13

Upadacitinib in patients with psoriatic arthritis and an in..:

McInnes, Iain B ; Kato, Koji ; Magrey, Marina...
RMD Open. 7 (2021) 3 - p. e001838 , 2021

Link: https://doi.org/10.1136/..

14

A review of JAK–STAT signalling in the pathogenesis of spon..:

McInnes, Iain B ; Szekanecz, Zoltán ; McGonagle, Dennis...
Rheumatology. 61 (2021) 5 - p. 1783-1794 , 2021

Link: https://doi.org/10.1093/..

15

Treatment Mode Preferences in Psoriatic Arthritis: A Qualit..:

Aletaha, Daniel ; Husni, M Elaine ; Merola, Joseph F...
Patient Preference and Adherence. 14 (2020) - p. 949-961 , 2020

Link: https://doi.org/10.2147/..